These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 1376299

  • 1. Immunorecognition of different ganglioside epitopes on human normal and melanoma tissues.
    Bernhard H, Roth S, Bauerschmitz J, Meyer zum Büschenfelde KH, Dippold W.
    Int J Cancer; 1992 Jun 19; 51(4):568-72. PubMed ID: 1376299
    [Abstract] [Full Text] [Related]

  • 2. Immunorecognition of ganglioside epitopes: correlation between affinity and cytotoxicity of ganglioside antibodies.
    Dippold W, Bernhard H.
    Eur J Cancer; 1992 Jun 19; 28A(10):1605-10. PubMed ID: 1382491
    [Abstract] [Full Text] [Related]

  • 3. Generation of monoclonal antibodies specific for ganglioside lactones: evidence of the expression of lactone on human melanoma cells.
    Kawashima I, Kotani M, Ozawa H, Suzuki M, Tai T.
    Int J Cancer; 1994 Jul 15; 58(2):263-8. PubMed ID: 8026889
    [Abstract] [Full Text] [Related]

  • 4. An epitope common to gangliosides O-acetyl-GD3 and GD3 recognized by antibodies in melanoma patients after active specific immunotherapy.
    Ravindranath MH, Morton DL, Irie RF.
    Cancer Res; 1989 Jul 15; 49(14):3891-7. PubMed ID: 2472199
    [Abstract] [Full Text] [Related]

  • 5. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues.
    Real FX, Houghton AN, Albino AP, Cordon-Cardo C, Melamed MR, Oettgen HF, Old LJ.
    Cancer Res; 1985 Sep 15; 45(9):4401-11. PubMed ID: 4028024
    [Abstract] [Full Text] [Related]

  • 6. Common phenotypic expression of gangliosides GM3 and GD3 in normal human tissues and neoplastic skin lesions.
    Nakakuma H, Horikawa K, Kawaguchi T, Hidaka M, Nagakura S, Hirai S, Kageshita T, Ono T, Kagimoto T, Iwamori M.
    Jpn J Clin Oncol; 1992 Oct 15; 22(5):308-12. PubMed ID: 1469793
    [Abstract] [Full Text] [Related]

  • 7. Ganglioside expression on human malignant melanoma assessed by quantitative immune thin-layer chromatography.
    Hamilton WB, Helling F, Lloyd KO, Livingston PO.
    Int J Cancer; 1993 Feb 20; 53(4):566-73. PubMed ID: 8436430
    [Abstract] [Full Text] [Related]

  • 8. Variations in the ganglioside profile of uveal melanoma correlate with cytologic heterogeneity.
    Kanda S, Cochran AJ, Lee WR, Morton DL, Irie RF.
    Int J Cancer; 1992 Nov 11; 52(5):682-7. PubMed ID: 1428227
    [Abstract] [Full Text] [Related]

  • 9. Ganglioside antigens in tissue sections of skin, naevi, and melanoma--implications for treatment of melanoma.
    Hersey P.
    Cancer Treat Res; 1991 Nov 11; 54():137-51. PubMed ID: 1673856
    [Abstract] [Full Text] [Related]

  • 10. Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins.
    Cheresh DA, Pierschbacher MD, Herzig MA, Mujoo K.
    J Cell Biol; 1986 Mar 11; 102(3):688-96. PubMed ID: 3005335
    [Abstract] [Full Text] [Related]

  • 11. Immunohistochemical localization of ganglioside GD3 in human malignant melanoma, epithelial tumors, and normal tissues.
    Dippold WG, Dienes HP, Knuth A, Meyer zum Büschenfelde KH.
    Cancer Res; 1985 Aug 11; 45(8):3699-705. PubMed ID: 3893688
    [Abstract] [Full Text] [Related]

  • 12. [Biochemistry of melanoma-associated ganglioside antigens].
    Hirabayashi Y, Higashi H, Taniguchi M.
    Gan To Kagaku Ryoho; 1986 Mar 11; 13(3 Pt 2):834-40. PubMed ID: 2421644
    [Abstract] [Full Text] [Related]

  • 13. Detection of GD3 ganglioside in primary melanomas depends on histopathologic procedures used for tumor preservation.
    Debarbieux S, Popa I, Thomas L, Kanitakis J, Pirot F, Portoukalian J, Haftek M.
    Acta Dermatovenerol Croat; 2009 Mar 11; 17(3):209-16. PubMed ID: 19818222
    [Abstract] [Full Text] [Related]

  • 14. Two human monoclonal antibodies reacting with the major gangliosides of human melanomas and comparison with corresponding mouse monoclonal antibodies.
    Furukawa K, Yamaguchi H, Oettgen HF, Old LJ, Lloyd KO.
    Cancer Res; 1989 Jan 01; 49(1):191-6. PubMed ID: 2908845
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Ganglioside GD3 shedding by human malignant melanoma cells.
    Bernhard H, Meyer zum Büschenfelde KH, Dippold WG.
    Int J Cancer; 1989 Jul 15; 44(1):155-60. PubMed ID: 2744885
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ganglioside profiles of experimental melanomas and of their melanosomal fractions.
    Vedralová E, Borovanský J, Hach P.
    Melanoma Res; 1995 Apr 15; 5(2):87-92. PubMed ID: 7620344
    [Abstract] [Full Text] [Related]

  • 20. Structural and immunological characterization of O-acetylated GD2. Evidence that GD2 is an acceptor for ganglioside O-acetyltransferase in human melanoma cells.
    Sjoberg ER, Manzi AE, Khoo KH, Dell A, Varki A.
    J Biol Chem; 1992 Aug 15; 267(23):16200-11. PubMed ID: 1644805
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.